← Eichor
Condition: Stage Ii Endometrial Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Stage Ii Endometrial Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06413992Postoperative Hypofractionated Whole Pelvic Radiotherapy in Cervical and Endometrial Cancer
NA · 1 location(s) · Siriraj Hospital · NCT07595224Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer
Phase 2 · 1 location(s) · Women's Hospital School Of Medicine Zhejiang University · NCT06561308Endometrial Cancer Lymphadenectomy Trial
NA · 61 location(s) · Philipps University Marburg · NCT03438474Cs-131LDR Brachytherapy for Organ-Preserving Irradiation for Recurrent Cervical and Endometrial Cancer
NA · 1 location(s) · Denise Fabian · NCT07631572Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
Phase N/A · 1 location(s) · Mayo Clinic · NCT07062016An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV
NA · 1 location(s) · Roswell Park Cancer Institute · NCT06855706Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · 409 location(s) · National Cancer Institute (NCI) · NCT05256225A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Phase 1/Phase 2 · 14 location(s) · Volastra Therapeutics, Inc. · NCT05902988A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07318415A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patien
Phase 1/Phase 2 · 1 location(s) · Shenzhen Ionova Life Sciences Co., Ltd. · NCT07610798Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer
NA · 1 location(s) · Rutgers, The State University of New Jersey · NCT07643012Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Phase 2 · 114 location(s) · Canadian Cancer Trials Group · NCT05640999A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Phase 1/Phase 2 · 21 location(s) · Alliance Foundation Trials, LLC. · NCT04486352A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07209449Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer
Phase 2 · 1 location(s) · Alessandro Santin · NCT03832361Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer
Phase 1/Phase 2 · 5 location(s) · University of Chicago · NCT04683653PROfiling Based Endometrial Cancer Adjuvant Therapy
NA · 10 location(s) · Women's Hospital School Of Medicine Zhejiang University · NCT05179447Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TRO
Phase 2 · 96 location(s) · AstraZeneca · NCT05489211Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade En
Phase 2 · 1 location(s) · University College, London · NCT05080556Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors.
Phase 2 · 4 location(s) · Gustave Roussy, Cancer Campus, Grand Paris · NCT07303387A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor
Phase 1/Phase 2 · 14 location(s) · Huabo Biopharm Co., Ltd. · NCT06758557Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
Phase 3 · 5 location(s) · University of Utah · NCT03422198An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
Phase 1/Phase 2 · 3 location(s) · Beijing Tide Pharmaceutical Co., Ltd · NCT07371663Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer
Phase 2 · 19 location(s) · 3D Medicines (Sichuan) Co., Ltd. · NCT05112991Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
Phase 1/Phase 2 · 1 location(s) · University of Alabama at Birmingham · NCT05559879A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurr
Phase 2 · 27 location(s) · Yonsei University · NCT06023862Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study
NA · 2 location(s) · Tata Memorial Centre · NCT05857631Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT04469764
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.